AYTU BIOPHARMA, INC. Lead Drug Candidate Success Prediction

Derived from AYTU BIOPHARMA, INC (AYTU) (CIK 0001385818) 10-Q filing analysis

Implied probability (Yes)

55%

Closes

2027-06-30